Table of Contents
International Journal of Proteomics
Volume 2012 (2012), Article ID 897412, 10 pages
http://dx.doi.org/10.1155/2012/897412
Review Article

Biomarker Discovery of Pancreatic and Gastrointestinal Cancer by 2DICAL: 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry

1Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
2Third Department of Surgery, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
3Institute for Stem Cell Biology and Regenerative Medicine (ISCBRM) and Stanford Cancer Center, Stanford University, 265 Campus Drive, Room G2015, Stanford, CA 94305, USA
4Bio Science Department, Research and Development Center, Mitsui Knowledge Industry Co., Ltd., 2-7-14 Higashinakano, Nakano-Ku, Tokyo 164-8555, Japan

Received 2 March 2012; Accepted 18 April 2012

Academic Editor: Fumio Nomura

Copyright © 2012 Masaya Ono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. L. Anderson and N. G. Anderson, “The human plasma proteome: history, character, and diagnostic prospects,” Molecular & Cellular Proteomics, vol. 1, no. 11, pp. 845–867, 2002. View at Google Scholar · View at Scopus
  2. S. P. Gygi, B. Rist, S. A. Gerber, F. Turecek, M. H. Gelb, and R. Aebersold, “Quantitative analysis of complex protein mixtures using isotope-coded affinity tags,” Nature Biotechnology, vol. 17, no. 10, pp. 994–999, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. L. DeSouza, G. Diehl, M. J. Rodrigues et al., “Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry,” Journal of Proteome Research, vol. 4, no. 2, pp. 377–386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ono, M. Shitashige, K. Honda et al., “Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectromery,” Molecular and Cellular Proteomics, vol. 5, no. 7, pp. 1338–1347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ono, J. Matsubara, K. Honda et al., “Prolyl 4-hydroxylation of α-fibrinogen. A novel protein modification revealed by plasma proteomics,” Journal of Biological Chemistry, vol. 284, no. 42, pp. 29041–29049, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Honda, Y. Hayashida, T. Umaki et al., “Possible detection of pancreatic cancer by plasma protein profiling,” Cancer Research, vol. 65, no. 22, pp. 10613–10622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ogata, T. Muramatsu, and A. Kobata, “Fractionation of glycopeptides by affinity column chromatography on concanavalin A Sepharose,” Journal of Biochemistry, vol. 78, no. 4, pp. 687–696, 1975. View at Google Scholar · View at Scopus
  8. A. Negishi, M. Ono, Y. Handa et al., “Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry,” Cancer Science, vol. 100, no. 3, pp. 514–519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Tanaka, H. Akiyama, T. Kuroda et al., “A novel approach and protocol for discovering extremely low-abundance proteins in serum,” Proteomics, vol. 6, no. 17, pp. 4845–4855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Matsubara, K. Honda, M. Ono et al., “Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 1, pp. 160–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Matsubara, M. Ono, K. Honda et al., “Survival prediction for pancreatic cancer patients receiving gemcitabine treatment,” Molecular and Cellular Proteomics, vol. 9, no. 4, pp. 695–704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Murakoshi, K. Honda, S. Sasazuki et al., “Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray,” Cancer Science, vol. 102, no. 3, pp. 630–638, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. M. H. Finlay, D. E. Games, J. R. Startin, and J. Gilbert, “Screening, confirmation, and quantification of sulphonamide residues in pig kidney by tandem mass spectrometry of crude extracts,” Biomedical and Environmental Mass Spectrometry, vol. 13, no. 11, pp. 633–639, 1986. View at Google Scholar · View at Scopus
  14. T. Grote, D. R. Siwak, H. A. Fritsche et al., “Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer,” Proteomics, vol. 8, no. 15, pp. 3051–3060, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Wulfkuhle, L. A. Liotta, and E. F. Petricoin, “Proteomic applications for the early detection of cancer,” Nature Reviews Cancer, vol. 3, no. 4, pp. 267–275, 2003. View at Google Scholar · View at Scopus
  16. J. Matsubara, K. Honda, M. Ono et al., “Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray,” Cancer Epidemiology, Biomarkers and Prevention, vol. 20, no. 10, pp. 2195–2203, 2011. View at Google Scholar
  17. J. Matsubara, M. Ono, A. Negishi et al., “Identification of a predictive biomarker for hematologic toxicities of gemcitabine,” Journal of Clinical Oncology, vol. 27, no. 13, pp. 2261–2268, 2009. View at Publisher · View at Google Scholar · View at Scopus